An in vitro study of MSC’s effects on aβ-treated neural cells showed positive effects through modulation of mTOR, AMPK, GSK-3β and Wnt/β-catenin pathways which are related to AD pathology, suggesting therapeutic potential of MSC therapy on AD [122]. Here, MTOR is linked to Alzheimer disease.